FEATURE ARTICLES
In her opening presentation, Harney noted that there were 98 drug shortages in 2024, 40 medicines in shortage for over three years, and the average duration of a shortage has increased from three years to four years.
- Risk-Based Analytical Method Selection In Cleaning Validation Using ASTM International Standards
- Eco-Friendly HBL: Cheaper, Cleaner, And Ready For Pharma
- Import Product Specifications And Drug Registration Testing For China
- Trust But Verify: Validating AI In Pharma's GxP World
- Roll Call In The Oral GLP-1 Race
- Derisking AI Means First Asking: Who Does It Serve?
- Defining Strong Program Management In CDMO Partnerships
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1087218944 Scientists In Sterile Suits Working With Computers In The Laboratory]( "Meet Regulation Requirements With RTU Vials And Cartridges")
Meet Regulation Requirements With RTU Vials And CartridgesSterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.
-
Advances In Regulations For Viable Environmental Monitoring2/21/2025
Viable air monitoring is critical for environmental monitoring programs in pharmaceutical manufacturing. Explore current regulatory standards as well as the impact of the EU GMP Annex 1 revisions.
-
Automated Validation And Centralized Data7/23/2025
Discover how intelligent CPV, powered by automation and real-time analytics, is transforming manufacturing by driving quality, compliance, and innovation in a rapidly evolving regulatory landscape.
-
Understanding Viral Clearance During Anion-Exchange Chromatography3/26/2024
A design of experiments (DoE) study examined the anion-exchange process in general and to draw possible correlations between such properties and overall viral clearance capability.
-
Overload Setting – Tricks And Techniques9/23/2024
Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.
-
Navigating The FDA's Drug Supply Chain Security Act3/14/2025
Explore the transformative impact of the DSCSA on the pharmaceutical industry, which ensures stringent standards, prevents counterfeit drugs, and enhances traceability for both large corporations and small manufacturers.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Seed Train Intensification Using High Cell Density Cryopreservation
- Developing A Large-Scale Tangential Flow Filtration Process
- Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
- Optimizing Human iPSC Aggregate And Organoid Production For Bioprinting
- Breaking Barriers In Malaria Prevention With A Mobile Cleanroom
NEWSLETTER ARCHIVE
- 10.16.25 -- 10 Ways To Strengthen U.S. API: Part I
- 10.16.25 -- STREAM Edition: Improving Peptide Yields Upstream
- 10.15.25 -- The Future Of Oral Solid Dose: Technologies Shaping Tomorrow's Treatments
- 10.15.25 -- The Case for Real-Time Facility Monitoring
- 10.15.25 -- Accelerating Pharma 4.0: Intelligent Validation, Modular Automation, And AI-Driven Quality
INDUSTRY NEWS
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
-
![Healthcare-GettyImages-1287539899]( "Spray Drying Market Poised To Nearly Double By 2033")
Spray Drying Market Poised To Nearly Double By 2033The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.
-
![Psychedelic Drugs-GettyImages-157676497]( "AbbVie Enters Psychedelic Market With Bretisilocin Acquisition")
AbbVie Enters Psychedelic Market With Bretisilocin AcquisitionBretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Ensera Launches As New Brand Identity For SteriPack10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US10/14/2025
Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.
-
Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility10/10/2025
Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.
-
Lupin To Build New Drug Manufacturing Facility In Coral Springs, Florida10/10/2025
Global pharmaceutical leader, Lupin, today announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, a significant step in safeguarding the health and safety of Florida families and the nation.
-
Groninger Invests In The Future: Building A state-Of-The-Art Assembly Hall At Its Crailsheim Headquarters10/8/2025
groninger is expanding: A new assembly hall and adjoining office complex are being built, covering more than 75,000 square feet. With an investment volume of over 30 million euros, it marks the largest single investment in the company’s history.
